Department of Physiology and Pathohysiology, School of Basic Medical Science, Shandong University, Jinan 250012, China.
Department of Pathology, School of Basic Medical Science, Shandong University, Jinan 250012, China.
Clin Sci (Lond). 2019 Feb 8;133(3):449-464. doi: 10.1042/CS20180919. Print 2019 Feb 14.
The intestinal ischemia/reperfusion (I/R) injury is a common clinical event related with high mortality in patients undergoing surgery or trauma. Estrogen exerts salutary effect on intestinal I/R injury, but the receptor type is not totally understood. We aimed to identify whether the G protein-coupled estrogen receptor (GPER) could protect the intestine against I/R injury and explored the mechanism. Adult male C57BL/6 mice were subjected to intestinal I/R injury by clamping (45 min) of the superior mesenteric artery followed by 4 h of intestinal reperfusion. Our results revealed that the selective GPER blocker abolished the protective effect of estrogen on intestinal I/R injury. Selective GPER agonist G-1 significantly alleviated I/R-induced intestinal mucosal damage, neutrophil infiltration, up-regulation of TNF-α and cyclooxygenase-2 (Cox-2) expression, and restored impaired intestinal barrier function. G-1 could ameliorate the impaired crypt cell proliferation ability induced by I/R and restore the decrease in villus height and crypt depth. The up-regulation of inducible nitric oxide synthase (iNOS) expression after I/R treatment was attenuated by G-1 administration. Moreover, selective iNOS inhibitor had a similar effect with G-1 on promoting the proliferation of crypt cells in the intestinal I/R model. Both GPER and iNOS were expressed in leucine-rich repeat containing G-protein coupled receptor 5 (Lgr5) positive stem cells in crypt. Together, these findings demonstrate that GPER activation can prompt epithelial cell repair following intestinal injury, which occurred at least in part by inhibiting the iNOS expression in intestinal stem cells (ISCs). GPER may be a novel therapeutic target for intestinal I/R injury.
肠缺血/再灌注(I/R)损伤是与手术或创伤相关的高死亡率的常见临床事件。雌激素对肠 I/R 损伤具有有益作用,但受体类型尚不完全清楚。我们旨在确定 G 蛋白偶联雌激素受体(GPER)是否可以保护肠道免受 I/R 损伤,并探讨其机制。成年雄性 C57BL/6 小鼠通过夹闭(45 分钟)肠系膜上动脉然后进行 4 小时的肠再灌注来进行肠 I/R 损伤。我们的结果表明,选择性 GPER 阻断剂消除了雌激素对肠 I/R 损伤的保护作用。选择性 GPER 激动剂 G-1 可显著减轻 I/R 引起的肠黏膜损伤、中性粒细胞浸润、TNF-α 和环氧化酶-2(Cox-2)表达上调,并恢复受损的肠屏障功能。G-1 可改善 I/R 引起的隐窝细胞增殖能力受损,并恢复绒毛高度和隐窝深度的降低。I/R 处理后诱导型一氧化氮合酶(iNOS)表达的上调被 G-1 给药减弱。此外,选择性 iNOS 抑制剂对促进肠 I/R 模型中隐窝细胞增殖的作用与 G-1 相似。GPER 和 iNOS 均在隐窝中的富含亮氨酸重复的 G 蛋白偶联受体 5(Lgr5)阳性干细胞中表达。总之,这些发现表明,GPER 激活可以促进肠损伤后的上皮细胞修复,至少部分通过抑制肠道干细胞(ISCs)中的 iNOS 表达来实现。GPER 可能是肠 I/R 损伤的新治疗靶点。